Feb 23, 2026 06:28AM
Feb 17, 2026 11:01AM
Jan 28, 2026 06:42AM
Jan 20, 2026 06:39AM
Dec 8, 2025 04:15AM
Dec 7, 2025 07:50AM
Dec 7, 2025 07:50AM Genmab reports positive phase 3 trial results for lymphoma therapy
Dec 7, 2025 07:50AM
Dec 7, 2025 07:50AM
Nov 18, 2025 11:30AM
Nov 18, 2025 11:30AM
Nov 10, 2025 06:48AM
Nov 6, 2025 11:02AM
Nov 3, 2025 09:05AM Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
Oct 18, 2025 06:00AM
Sep 29, 2025 01:08AM
Sep 29, 2025 01:08AM
Sep 3, 2025 08:30AM
Sep 3, 2025 08:30AM
Aug 19, 2025 08:01AM
Aug 19, 2025 08:00AM SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
Aug 15, 2025 06:51AM
Aug 7, 2025 11:08AM
Aug 7, 2025 10:30AM
Aug 7, 2025 10:30AM
Aug 7, 2025 10:30AM
Aug 7, 2025 10:30AM
May 1, 2025 08:24PM Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R²) in Patients with Relapsed/Refractory Folli
May 1, 2025 08:14PM
Mar 17, 2025 12:19PM
Mar 17, 2025 12:19PM
Feb 12, 2025 11:01AM
Dec 21, 2024 10:00AM
Dec 7, 2024 07:00PM
Sep 20, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)
Sep 15, 2024 08:45AM
Aug 8, 2024 11:03AM
Jun 27, 2024 06:37AM
Jun 27, 2024 05:08AM
Jun 26, 2024 07:03PM
May 23, 2024 05:00PM
May 21, 2024 11:07AM Genmab A/S (GMAB) Completes Acquisition of ProfoundBio
May 21, 2024 11:06AM
May 2, 2024 11:01AM
Apr 29, 2024 06:55PM
Apr 29, 2024 06:40PM
Apr 29, 2024 06:40PM
Apr 3, 2024 05:41AM
Apr 3, 2024 01:34AM Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
Feb 27, 2024 07:45AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All